Cargando…

Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma

PURPOSE: We aimed to determine the prognostic significance of lymphocyte counts and the lymphocytemonocyte ratio (LMR) in pediatric patients with osteosarcoma. METHODS: We retrospectively reviewed the medical records of 27 pediatric patients with localized extremity osteosarcoma, treated at the Kore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jun Ah, Oh, Hea Lin, Kim, Dong Ho, Lim, Jung Sub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Pediatric Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382963/ https://www.ncbi.nlm.nih.gov/pubmed/30304898 http://dx.doi.org/10.3345/kjp.2018.06618

Ejemplares similares

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with Ifosfamide-Doxorubicin for Osteosarcoma
por: Samimi, Mozhgan Aalam, et al.
Publicado: (2014)

Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma
por: Yapar, Aliekber, et al.
Publicado: (2021)

Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma
por: Ahn, Ju Hyun, et al.
Publicado: (2015)

The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy
por: Zhou, Danyang, et al.
Publicado: (2020)

Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis
por: Peng, Li-Peng, et al.
Publicado: (2022)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
por: Krakowska, Magdalena, et al.
Publicado: (2018)

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
por: Park, Se Hoon, et al.
Publicado: (2006)

Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma
por: Liu, Tao, et al.
Publicado: (2015)

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
por: McTiernan, Anne, et al.
Publicado: (2012)

Total Neoadjuvant vs. Standard Perioperative Cisplatin/Doxorubicin Chemotherapy in Patients with Extremities Osteosarcoma: A Multi-Center Cohort Study
por: Foroughi, Ahmad, et al.
Publicado: (2023)

Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
por: Halalsheh, Hadeel, et al.
Publicado: (2023)

Monocyte, Lymphocyte and Neutrophil Ratios – Easy-to-Use Biomarkers for the Diagnosis of Pediatric Tuberculosis
por: Kissling, Mirjam, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in different etiological causes of thyrotoxicosis
por: TAŞKALDIRAN, Işılay, et al.
Publicado: (2019)

Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19
por: Seyit, Murat, et al.
Publicado: (2021)

Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19
por: Seyit, Murat, et al.
Publicado: (2021)

Predicting Chemotherapy Resistance in Gestational Trophoblastic Neoplasia: Ratio of Neutrophils, Lymphocytes, Monocytes, and Platelets
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2022)

In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment
por: Si, Meng, et al.
Publicado: (2022)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratio in Bipolar Disorder
por: Fusar-Poli, Laura, et al.
Publicado: (2021)

Lymphocyte-to-Monocyte Ratio Is an Independent Predictor for Neurological Deterioration and 90-Day Mortality in Spontaneous Intracerebral Hemorrhage
por: Qi, Haijun, et al.
Publicado: (2018)

Prognostic Role of Lymphocyte/Monocyte Ratio in Chronic Lymphocytic Leukemia
por: Yokus, Osman, et al.
Publicado: (2020)

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2017)

Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2021)

Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients
por: Shang, Qi-Xin, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio predict length of hospital stay in myocarditis
por: Mirna, Moritz, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio in Depression: An Updated Systematic Review and Meta-Analysis
por: Cheng, Yanwei, et al.
Publicado: (2022)

Impact on the survival of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and monocyte-lymphocyte ratio on prognosis in children with Hodgkin lymphoma
por: Ertan, Kubra, et al.
Publicado: (2022)

Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in ADHD: a systematic review and meta-analysis
por: Gędek, Adam, et al.
Publicado: (2023)

Evaluation of monocyte-to-high-density lipoprotein cholesterol ratio and monocyte-to-lymphocyte ratio in ischemic stroke
por: Liu, Huiling, et al.
Publicado: (2020)

Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin
por: Graat, H C A, et al.
Publicado: (2006)

Efficiency of Monocyte/High-Density Lipoprotein Cholesterol Ratio Combined With Neutrophil/Lymphocyte Ratio in Predicting 28-Day Mortality in Patients With Sepsis
por: Li, Jing-yan, et al.
Publicado: (2021)

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
por: Shi, Lihui, et al.
Publicado: (2016)

Preoperative Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Peripheral Blood of Patients with Gastrointestinal Malignant Lesions
por: PETRESCU, MO, et al.
Publicado: (2019)

Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis
por: Liao, Jiaxian, et al.
Publicado: (2022)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
por: Lim, Se Won, et al.
Publicado: (2016)

Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis()()
por: Aktaş Karabay, Ezgi, et al.
Publicado: (2020)

Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy
por: Lin, Gui-Nan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ksf60f96etunm7nrgddmh59h5c